{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:11:51Z","timestamp":1786990311681,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ijantimicag.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T14:28:39Z","timestamp":1523543319000},"page":"195-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["The impact of antibiotic prescription rates on the incidence of MRSA bloodstream infections: A county-level, US-wide analysis"],"prefix":"10.1016","volume":"52","author":[{"given":"Nikolaos","family":"Andreatos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Shehadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina Eleftheria","family":"Pliakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0001","unstructured":"Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States. Available from: https:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/pdf\/ar-threats-2013-508.pdf#page=77. [Accessed 22 October 2017]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0002","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1086\/651094","article-title":"Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection","volume":"31","author":"Filice","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 3","key":"10.1016\/j.ijantimicag.2018.04.003_bib0003","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1086\/519473","article-title":"Epidemiology of staphylococcal resistance","volume":"45","author":"Shorr","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0004","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-0711-5-2","article-title":"Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States","volume":"5","author":"Styers","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0006","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","article-title":"National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004","volume":"32","year":"2004","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0007","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/345476","article-title":"Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis","volume":"36","author":"Cosgrove","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0008","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/archinte.162.19.2229","article-title":"Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus","volume":"162","author":"Blot","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0009","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5694\/j.1326-5377.2001.tb143562.x","article-title":"Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis","volume":"175","author":"Whitby","year":"2001","journal-title":"Med J Aust"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0010","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/502522","article-title":"The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges","volume":"26","author":"Cosgrove","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0011","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1086\/502523","article-title":"Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia","volume":"26","author":"Reed","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0012","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1086\/501641","article-title":"Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs?","volume":"20","author":"Abramson","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0013","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1073\/pnas.122108599","article-title":"The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"99","author":"Enright","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0014","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/432056","article-title":"Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals","volume":"41","author":"MacDougall","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jac\/42.5.676","article-title":"Antibiotic usage and methicillin-resistant Staphylococcus aureus: an analysis of causality","volume":"42","author":"Hill","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0016","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3201\/eid1307.061561","article-title":"Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom","volume":"13","author":"Schneider-Lindner","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/01.qai.0000179464.40948.b9","article-title":"Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults","volume":"40","author":"Mathews","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0018","first-page":"197","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients\u2013United States, 2005","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0019","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1179\/2047773214Y.0000000154","article-title":"Socio-economic profile of patients with community-acquired skin and soft tissue infections in Delhi","volume":"108","author":"Ravishankar","year":"2014","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2334-12-249","article-title":"Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians","volume":"12","author":"Tong","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0021","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1017\/S0950268812001872","article-title":"A population-based study of the epidemiology and clinical features of methicillin-resistant Staphylococcus aureus infection in Pennsylvania, 2001\u20132010","volume":"141","author":"Casey","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0022","unstructured":"Centers for Medicare & Medicaid Services. Hospital Compare data archive. Available from: https:\/\/data.medicare.gov\/data\/archives\/hospital-compare. [Accessed 10 July 2017]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0023","unstructured":"Centers for Medicare & Medicaid Services. Healthcare-associated infections. Available from: https:\/\/www.medicare.gov\/hospitalcompare\/Data\/Healthcare-Associated-Infections.html. [Accessed 10 March 2018]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0024","unstructured":"Centers for Disease Control and Prevention. Troubleshooting the MRSA Bacteremia and CDI LabID Event SIR. Available from: https:\/\/www.cdc.gov\/nhsn\/pdfs\/ps-analysis-resources\/mrsacdi_tips.pdf. [Accessed 10 March 2018]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0025","unstructured":"The Dartmouth Atlas of Healthcare. Atlas Geographic Crosswalks and Boundary Files. Available from: http:\/\/www.dartmouthatlas.org\/tools\/downloads.aspx. [Accessed 10 July 2017]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0026","unstructured":"United States Department of Housing and Urban Development. USPS ZIP Code Crosswalk Files. Available from: https:\/\/www.huduser.gov\/portal\/datasets\/usps_crosswalk.html. [Accessed 10 July 2017]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0027","unstructured":"United States Census Bureau. American Fact Finder. Available from: https:\/\/factfinder.census.gov\/faces\/nav\/jsf\/pages\/index.xhtml. [Accessed 10 July 2017]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0028","unstructured":"United States Census Bureau. Selected Housing Characteristics 2011\u20132015: American Community Survey 5-Year Estimates. Available from: https:\/\/factfinder.census.gov\/bkmk\/table\/1.0\/en\/ACS\/15_5YR\/DP04\/. [Accessed 10 July 2017]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0029","unstructured":"United States Census Bureau. Selected Characteristics of the Total and Native Populations in the United States: 2011\u20132015 American Community Survey 5-Year Estimates. Available from: https:\/\/factfinder.census.gov\/bkmk\/table\/1.0\/en\/ACS\/15_5YR\/S0601\/. [Accessed 10 July 2017]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0030","unstructured":"Centers for Medicare & Medicaid Services. Medicare Provider Utilization and Payment Data: Part D Prescriber Public Use File (PUF) Available from: https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and-Reports\/Medicare-Provider-Charge-Data\/Part-D-Prescriber.html. [Accessed 10 July 2017]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0031","unstructured":"The Henry J. Kaiser Family Foundation. Medicare Part D Prescription Drug Plans: The Marketplace in 2013 and Key Trends, 2006\u20132013. Available from: https:\/\/www.kff.org\/medicare\/issue-brief\/medicare-part-d-prescription-drug-plans-the-marketplace-in-2013-and-key-trends-2006-2013\/. [Accessed 25 October 2017]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0032","unstructured":"The Henry J. Kaiser Family Foundation. Medicare Part D at Ten Years: The 2015 Marketplace and Key Trends, 2006\u20132015. Available from: https:\/\/www.kff.org\/medicare\/report\/medicare-part-d-at-ten-years-the-2015-marketplace-and-key-trends-2006-2015\/. [Accessed 25 October 2017]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0033","unstructured":"Centers for Medicare & Medicaid Services. Medicare Enrollment Dashboard. Available from: https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Statistics-Trends-and-Reports\/CMSProgramStatistics\/Dashboard.html. [Accessed 10 March 2018]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0034","unstructured":"Environmental Systems Research Institute (ESRI). ArcGIS mapping software Available from: http:\/\/www.esri.com\/arcgis\/about-arcgis. [Accessed 22 October 2017]."},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S0195941700065814","article-title":"Variation in methicillin-resistant Staphylococcus aureus occurrence by geographic location and hospital characteristics","volume":"8","author":"Wakefield","year":"1987","journal-title":"Infect Control"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0036","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3201\/eid1106.040831","article-title":"Methicillin-resistant-Staphylococcus aureus hospitalizations, United States","volume":"11","author":"Kuehnert","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.ijantimicag.2018.04.003_bib0037","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1086\/533590","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus","volume":"46","author":"Boucher","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0038","first-page":"303","article-title":"Hospital-acquired methicillin-resistant Staphylococcus aureus bacteremia related to medicare antibiotic prescriptions: a state-level analysis","volume":"75","author":"Fukunaga","year":"2016","journal-title":"Hawaii J Med Public Health"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0039","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/cid\/cix640","article-title":"Trends in methicillin-resistant Staphylococcus aureus hospitalizations in the United States, 2010\u20132014","volume":"65","author":"Klein","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.04.003_bib0040","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/cid\/civ076","article-title":"US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011","volume":"60","author":"Hicks","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918301055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918301055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:38:17Z","timestamp":1751546297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918301055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0924857918301055"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.04.003","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of antibiotic prescription rates on the incidence of MRSA bloodstream infections: A county-level, US-wide analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}